Back to search

Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys

Data up to Jan 2025

Published1998
Citations101
References35

Total Citations Per Year

Abstract

References (35)

Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons

1985 • 527 citations

Nicotinic systems and cognitive function

1992 • 519 citations

The Effects of Nicotine on Attention, Information Processing, and Short-Term Memory in Patients with Dementia of the Alzheimer Type

1989 • 491 citations

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in alzheimer's disease

1992 • 478 citations

Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder

1994 • 445 citations

Nicotine effects on adults with attention-deficit/hyperactivity disorder

1996 • 415 citations

Intravenous nicotine in Alzheimer's disease: a pilot study

1988 • 312 citations

Modelling dementia: Effects of scopolamine on memory and attention

1988 • 211 citations

Chapter 15 Presynaptic modulation of transmitter release by nicotinic receptors

1989 • 200 citations

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.

1994 • 178 citations

Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task

1992 • 164 citations

Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys

1991 • 163 citations

Nicotine enhances delayed matching-to-sample performance by primates

1988 • 144 citations

The effects of cholinergic drugs and cholinergic-rich foetal neural transplants on alcohol-induced deficits in radial maze performance in rats

1991 • 142 citations

Lexical priming deficits as a function of age.

1990 • 131 citations

The Role of Frontal Dysfunction in Attention Deficit Hyperactivity Disorder

1991 • 101 citations

Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement

1995 • 100 citations

Effects of Stimulant Drugs on Academic Performance in Hyperactive and Learning Disabled Children

1983 • 98 citations

Evidence for a role of brain noradrenaline in attention and stimulus sampling

1978 • 96 citations

Pharmacologic Treatment of Attention Deficit Hyperactivity Disorder

1992 • 91 citations

Novel Isoxazoles which Interact with Brain Cholinergic Channel Receptors Have Intrinsic Cognitive Enhancing and Anxiolytic Activities

1994 • 88 citations

Effects of Concomitant Cholinergic and Adrenergic Stimulation on Learning and Memory Performance by Young and Aged Monkeys

1993 • 66 citations

Effects of Varying Irrelevant Information on Adult Age Differences in Problem Solving

1979 • 65 citations

Recent memory in aged non-human primates: Hypersensitivity to visual interference during retention

1979 • 65 citations

Structure−Activity Studies on 2-Methyl-3-(2(S)-pyrrolidinylmethoxy)pyridine (ABT-089): An Orally Bioavailable 3-Pyridyl Ether Nicotinic Acetylcholine Receptor Ligand with Cognition-Enhancing Properties

1997 • 63 citations

Nicotine and coronary heart disease

1991 • 60 citations

Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys

1993 • 60 citations

Activation and inhibition of rat neuronal nicotinic receptors by ABT‐418

1997 • 56 citations

Drug Treatment for Hyperactive Children

1993 • 45 citations

Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418

1997 • 43 citations

Potential Treatment of Alzheimer Disease Using Cholinergic Channel Activators (ChCAs) with Cognitive Enhancement, Anxiolytic-like, and Cytoprotective Properties

1995 • 43 citations

Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease

1995 • 39 citations

Cardiovascular effects of nicotine: Relation to deleterious effects of cigarette smoking

1994 • 34 citations

Mecamylamine blockade of nicotine enhanced noradrenaline turnover in rat brain

1979 • 28 citations

Antagonism of the nicotine-induced changes of the striatal dopamine metabolism in mice by mecamylamine and pempidine

1988 • 27 citations

Cited By (0)

Loading...
Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce… (1998) – Psychopharmacology | Metascience Observatory Explorer